Back to search results

The German ADPKD Tolvaptan Treatment Registry

Abroad (travel likely)Recruiting

Conditions

ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Fachinternistische Gemeinschaftspraxis Markgraeferland, Müllheim, Baden-Wurttemberg, Germany

    Contact: Study coordinator (Markus Cybulla, MD)
    Contact: Study coordinator (Gudrun Tech)
    Contact: Principal Investigator (Markus Cybulla, MD)

  • University Hospital of Wuerzburg, ZIM, Würzburg, Bavaria, Germany

    Contact: Study coordinator (Daniel Kraus, MD)
    Contact: Study coordinator (Kirsten Hofmann)
    Contact: Principal Investigator (Christoph Wanner, MD)
    Daniel Kraus, MD (Sub-investigator)

  • Medizinische Hochschule Hannover, Hanover, Lower Saxony, Germany

    Contact: Study coordinator (Roland Schmitt, MD)
    Contact: Study coordinator (Hermann Haller, MD)
    Contact: Principal Investigator (Roland Schmitt, MD)
    Hermann Haller, MD (Sub-investigator)

  • University Hospital of Cologne, Cologne, North Rhine-Westphalia, Germany

    Contact: Study coordinator (Thomas Benzing, MD) · thomas.benzing@uk-koeln.de · +49 221 478 97222
    Contact: Study coordinator (Roman-Ulrich Mueller, MD) · roman-ulrich.mueller@uk-koeln.de · +49 221 478 97222
    Roman-Ulrich Mueller, MD (Sub-investigator)
    Franziska Grundmann, MD (Sub-investigator)
    Katharina Burkert, MD (Sub-investigator)
    Polina Todorova (Sub-investigator)
    Victor Suarez, MD (Sub-investigator)
    Contact: Principal Investigator (Thomas Benzing, MD)

  • Nieren- und Diabeteszentrum Nettetal-Lobberich, Nettetal, North Rhine-Westphalia, Germany

  • University Hospital of Leipzig, Nephrologische Ambulanz, Leipzig, Saxony, Germany

    Contact: Study coordinator (Jan Halbritter, MD)
    Contact: Principal Investigator (Jan Halbritter, MD)

  • Praxisgemeinschaft Dr. Peschel, Leipzig, Saxony, Germany

    Contact: Study coordinator (Katrin Peschel, MD)
    Contact: Principal Investigator (Katrin Peschel, MD)

  • University Hospital of Schleswig-Holstein, Lübeck, Schleswig-Holstein, Germany

    Contact: Study coordinator (Figen Cakiroglu, MD)
    Contact: Study coordinator (Alexandra Tiedtke)
    Contact: Principal Investigator (Figen Cakiroglu, MD)

  • Nierenzentrum Lübeck, Lübeck, Schleswig-Holstein, Germany

    Contact: Study coordinator (Peter Gerke, MD)
    Contact: Study coordinator (Lutz Hennings)
    Contact: Principal Investigator (Peter Gerke, MD)

  • Charité Universitätsmedizin Berlin, Berlin, State of Berlin, Germany

  • University Hospital of Jena, Jena, Thuringia, Germany

    Contact: Study coordinator (Martin Busch, MD)
    Contact: Principal Investigator (Martin Busch, MD)

  • Robert-Bosch-Krankenhaus, Stuttgart, Germany

    Contact: Study coordinator (Dominik Alscher, MD)
    Contact: Study coordinator (David Callau Monje, MD)
    Contact: Principal Investigator (Dominik Alscher, MD)
    David Callau Monje, MD (Sub-investigator)
Study leads

  • Thomas Benzing, MD, Prof.

    Principal Investigator

    University Hospital of Cologne

  • Roman-Ulrich Müller, MD, Prof.

    Principal Investigator

    University Hospital Cologne

View source on ClinicalTrials.gov(opens in a new tab)